Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study.
Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy.
Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel.
Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3.
Principal Investigator
See All 12 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Principal Investigator
Overview
researcher role of
Bishop, Michael
contributes to
Developing Immunoablative Regimens for the Engraftment of Allogeneic HSCT